The small study in The Lancet Neurology used a virus to add genes to brain cells, which resulted in reduced symptoms for half of patients.
Home | Calendar of Events | Services | News | Resources | Products | Contact | Directory Search | Partner with Us | Media Partners | Link to Us | Terms of Use |
© 2019 Bioscreening.com